In juvenile idiopathic arthritis with a positive ANA, which specialty referral is most critical?

In juvenile idiopathic arthritis with a positive ANA, which specialty referral is most critical?

• A. Cardiology
• B. Ophthalmology
• C. Orthopedics
• D. Pain management

Answer: (B)

In juvenile idiopathic arthritis, positive ANA status signals a higher risk of developing anterior uveitis, an eye inflammation that often has few or no symptoms early on. Because uveitis can be silent yet cause serious eye damage if missed, an ophthalmology referral is essential for regular slit-lamp examinations and early detection. Early treatment guided by an eye specialist helps prevent complications such as synechiae, glaucoma, cataracts, and potential vision loss, making this referral the most critical for ANA-positive patients. Other specialties don’t address this specific and potentially vision-threatening risk as directly. Cardiology focuses on heart issues, orthopedics on joints and mechanics of movement, and pain management on symptom relief—they’re important in comprehensive care but don’t target the urgent ocular complication associated with ANA-positive JIA.

In juvenile idiopathic arthritis, positive ANA status signals a higher risk of developing anterior uveitis, an eye inflammation that often has few or no symptoms early on. Because uveitis can be silent yet cause serious eye damage if missed, an ophthalmology referral is essential for regular slit-lamp examinations and early detection. Early treatment guided by an eye specialist helps prevent complications such as synechiae, glaucoma, cataracts, and potential vision loss, making this referral the most critical for ANA-positive patients.

Other specialties don’t address this specific and potentially vision-threatening risk as directly. Cardiology focuses on heart issues, orthopedics on joints and mechanics of movement, and pain management on symptom relief—they’re important in comprehensive care but don’t target the urgent ocular complication associated with ANA-positive JIA.